AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
With a market cap of 299.17B, AstraZeneca(AZN) trades at $192.88. The stock has a price-to-earnings ratio of 29.30 and currently yields dividends of 1.6%.
On 2026-03-12, AstraZeneca(AZN) stock moved within a range of $190.97 to $194.78. With shares now at $192.88, the stock is trading +1.0% above its intraday low and -1.0% below the session's peak.
Trading volume for AstraZeneca(AZN) stock has reached 2.07M, versus its average volume of 2.07M.
The stock's 52-week range extends from a low of $122.48 to a high of $212.71.
The stock's 52-week range extends from a low of $122.48 to a high of $212.71.
AZN News
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. The DURGA-4 study, formally titled “A Phase III Open-label, Randomised, Multicent...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca study tracks how two versions of its asthma drug move through childre...
British drugmaker AstraZeneca Plc (NYSE:AZN) has emerged as the leading contender to acquire French biotech Abivax SA (NASDAQ:ABVX) , following the company's dr...
Analyst ratings
81%
of 31 ratingsMore AZN News
05:45 EDT Abivax (ABVX) jumps 15% to $129.11 after report of exclusivity with AstraZeneca (AZN) Published first on TheFly – the ultimate source for real-time,...
Abivax (ABVX) has granted AstraZeneca (AZN) an exclusive period through March 23 to access confidential information and formalize a potential takeover offer, La...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study “Specific Use-results Study of IMJUDO Intravenous Infusion 25 mg, 300 mg / I...
The latest update is out from AstraZeneca ( (GB:AZN) ). AstraZeneca has published the notice and shareholders’ circular for its 2026 Annual General Meeting, wh...
Keymed Biosciences, Inc. ( (HK:2162) ) has shared an update. Keymed Biosciences said partner AstraZeneca has begun a multi-center Phase III trial of CMG901, al...
Daiichi Sankyo and AstraZeneca’s (AZN) supplemental biologics license application for Enhertu has been accepted and granted priority review in the U.S. for the...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.